The number of people living with heart failure (HF) worldwide more than doubled between 1990 and 2023, reaching an estimated ...

Cost was cited at the top barrier to prescribing nonsteroidal mineralocorticoid antagonists (57%), sodium-glucose cotransporter 2 inhibitors (74%), and glucagon-like peptide 1 receptor agonists (84%).

The conference, held in New Orleans, Louisiana, by the American Academy of Ophthalmology, will offer 3 full days of content ...

Patients with early-onset, BRAF V600E–mutated metastatic colorectal cancer should receive combination therapy as soon as ...

Washington, DC, clinicians shared how order sets, pharmacist-led dosing, and better handoffs can close iron deficiency gaps ...

Michael Mina, MD, PhD, explains Invivyd's accelerated approval path for VYD2311 and how it could change the timing of COVID-19 protection. Invivyd plans to seek accelerated approval for VYD2311 based ...

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press. Insurance Business cited the AJMC study as evidence for its central argument: a larger PBM rebate ...

Esperion launched a nationwide awareness campaign for bumetanide nasal spray (Enbumyst), a short-term intranasal loop ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

The FDA approved tucatinib (Tukysa; Pfizer) in combination with trastuzumab and pertuzumab for the maintenance treatment of ...

Sacral neuromodulation (SNM) is still considered the gold standard neuromodulation option for refractory overactive bladder ...

Risk assessment in mantle cell lymphoma (MCL) is evolving beyond traditional clinical scores, as genomic and dynamic ...